Bli medlem
Bli medlem

Du är här

2015-03-26

NNIT A/S: 14/2015 Major shareholder announcement

Company announcement 14/2015

Søborg/Copenhagen, 26 March 2015

Major shareholder announcement

With reference to announcement no. 8 dated 6 March 2015 regarding major
shareholder notification and announcement no. 12 dated 26 March 2015
regarding exercise of the overallotment option in connection with the initial
public offering of shares in NNIT A/S (the "Overallotment Option"), NNIT A/S
("NNIT") hereby announces the receipt of the following notification pursuant
to Section 29 of the Danish Securities Trading Act regarding Novo Nordisk A/S
("Novo Nordisk"), Novo A/S and the Novo Nordisk Foundation's respective
direct and indirect holdings of shares in NNIT.

In connection with the exercise of the Overallotment Option, the 1,500,000
NNIT shares of a nominal value of DKK 10 each lent by Novo Nordisk to Danske
Bank A/S and Morgan Stanley&Co. International plc on behalf of the managers
under the stock lending agreement for the purposes of delivery of shares to
investors as a result of the Overallotment Option have today, 26 March 2015,
been settled.

Following settlement of the Overallotment Option, Novo Nordisk has a direct
holding of shares in NNIT of 6,375,000 shares in total of a nominal value of
DKK 10 each, corresponding to 25.5% of the share capital and 25.5% of the
voting rights in NNIT.

Novo Nordisk is a public limited company organised under the laws of Denmark
under CVR no. 24 25 67 90. Novo A/S is the parent company of Novo Nordisk
through its ownership of 26.46% of the total share capital and 73.97% of all
votes in Novo Nordisk. Novo A/S is a public limited company organised under
the laws of Denmark under CVR no. 24 25 76 30.

Following settlement of the Overallotment Option, Novo A/S has a direct and
indirect holding through Novo Nordisk of shares in NNIT of 12,750,000 shares
in total of a nominal value of DKK 10 each, corresponding to 51% of the share
capital and 51% of the voting rights in NNIT.

Novo A/S is wholly-owned by the Novo Nordisk Foundation. The Novo Nordisk
Foundation is a foundation organised under the laws of Denmark under CVR no.
10 58 29 89.

About NNIT

NNIT A/S is one of Denmark's leading IT service providers and consultancies.
NNIT A/S offers a wide range of IT services and solutions to its customers,
primarily in the life sciences sector in Denmark and internationally and to
customers in the public, enterprise and finance sectors in Denmark. As of 31
December 2014, NNIT A/S had more than 2,400 employees.

For more information please visitwww.nnit.com.

Enquiries

Media contacts:
Robert Neimanas, Head of Communications: +45 3079 7480, rbnm@nnit.com

Investor contacts:
Jesper Wagener, Head of Investor Relations: +45 3075 5392,jvwa@nnit.com

14/2015 Major shareholder announcement
http://hugin.info/163771/R/1906307/678631.pdf

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NNIT A/S via Globenewswire

HUG#1906307

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.